<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04250909</url>
  </required_header>
  <id_info>
    <org_study_id>C1901</org_study_id>
    <nct_id>NCT04250909</nct_id>
  </id_info>
  <brief_title>Retrospective Follow-up of BIOLUX P-I/-II</brief_title>
  <official_title>Retrospective 5-year Safety Analysis of the BIOLUX P-I and P-II Studies in Subjects Requiring Revascularization of Infrainguinal Arteries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to collect long-term clinical data from 132 patients from Belgium, Germany and
      Austria who had previously participated in either of the BIOLUX P-I or P-II studies. Patients
      in these studies were treated with either a percutaneous transluminal angioplasty (PTA)
      balloon catheter or a drug-coated Passe-18-Lux balloon (DCB). The purpose of Retro-BIOLUX
      P-I-II is to collect clinical data from patients treated with either Passeo-18 PTA or
      Passeo-18 Lux DCB to analyze the long-term effects.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>60 months</time_frame>
    <description>Overall survival at five years after index procedure, defined as death from any cause</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival, defined as the time in days after index procedure to date of death from any cause.</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major amputations of target extremities</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinically-driven target lesion revascularization</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cause of death (descriptive analysis) at five years after treatment within BIOLUX P-I/-II.</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Overall Mortality</condition>
  <arm_group>
    <arm_group_label>Passeo 18 PTA</arm_group_label>
    <description>Previous treatment with uncoated Passeo 18 PTA balloon catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Passeo-18 Lux DCB</arm_group_label>
    <description>Previous teatment with Passeo-18 Lux DCB</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Passeo-18</intervention_name>
    <description>POBA</description>
    <arm_group_label>Passeo 18 PTA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Passeo-18 Lux</intervention_name>
    <description>DCB</description>
    <arm_group_label>Passeo-18 Lux DCB</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from previous studies.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject was previously enrolled in either BIOLUX P-I or BIOLUX P-II

          2. Subject was treated either with Passeo-18 PTA or Passeo-18 LUX

          3. Written informed consent by subject or subject's legal representative or impartial
             witness/waiver

        Exclusion Criteria:

          1. Subject did neither participate in BIOLUX P-I nor BIOLUX P-II

          2. Subject was neither treated with Passeo-18 Lux nor with Passeo-18 PTA

          3. Subject is not willing to sign an informed consent /data release form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Zeller, Prof Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Clinic of Cardiology and Angiology II Bad Krozingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katharina Brett, Dr</last_name>
    <phone>+41448647620</phone>
    <email>katharina.brett@biotronik.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>LKH Univ.-Klinikum Graz, Ambulanz für Angiologie</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marianne Brodmann, Prof Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Eva Pock</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus - Universitätsklinik für Radiodiagnostik, Klinische Abteilung für Kardiovaskuläre und Interventionelle Radiologie</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Loewe, Prof Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vascular Research Center Bornheiden, Imelda Hospital</name>
      <address>
        <city>Bonheiden</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jürgen Verbist, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.Z. Sint-Blasius</name>
      <address>
        <city>Dendermonde</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koen Deloose, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic of Cardiology and Angiology II Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sonja Haberstroh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gefäßzentrum am KEH</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jan Theil, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Leipzig Medical Centre Medizinische Klinik und Poliklinik V (Angiologie)</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dierk Scheinert, Prof Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Nadine Richter</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Institut für Diagnostische und Interventionelle Radiologie, RoMed Klinikum</name>
      <address>
        <city>Rosenheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gunnar Tepe, Prof Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 30, 2020</study_first_submitted>
  <study_first_submitted_qc>January 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2020</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

